LabCorp
LabCorp
358 South Main Street
Burlington
NC
27215
United States
Tel: 336-229-1127
Fax: 336-513-4510
Website: http://www.jobs.labcorp.com/
About LabCorp
LabCorp is a leading global life sciences company. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories.
With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp processes tests on approximately 500,000 specimens each day, applying advances in medicine and science to laboratory testing.
LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 50,000 employees worldwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH.
291 articles about LabCorp
-
LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of COVID-19 Vaccines in Clinical Trials
10/19/2020
Quantitative Test is Used to Assess Immune Response and to Support Other Scientific Research
-
CLEAR Adds LabCorp COVID-19 Test Results to “Health Pass” Mobile App
10/5/2020
CLEAR, the secure identity company, and LabCorp, a leading global life sciences company that is focused on advancing health and guiding patient care decisions, announced a partnership to enable users of CLEAR’s Health Pass mobile app to securely link their LabCorp test results using their LabCorp Patient™ account.
-
LabCorp COVID-19 Molecular Test Innovation Receives FDA Authorization
10/2/2020
New Heat Extraction Scientific Testing Method and Technology Improves COVID-19 Molecular Test Efficiency and Throughput
-
The new high-speed test uses a high-throughput method comprising heat and technology to extract RNA from samples used for COVID-19 RT-PCR molecular testing.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
-
LabCorp and Infirmary Health Form Strategic Partnership to Provide Laboratory Services Across Healthcare System
9/29/2020
Multi-year deal will enhance lab services for patients and providers throughout eastern Gulf Coast region
-
LabCorp to Announce Third Quarter Financial Results on October 27, 2020
9/28/2020
LabCorp (NYSE: LH) will release its third quarter of 2020 financial results before the market opens on Tuesday, Oct. 27, 2020, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results. The earnings release and accompanying financial information will be posted on the LabCorp Investor Relations website . Interested parties can access the conference call by dialing 1-
-
New Non-Invasive Test for Lung Cancer Available Exclusively from LabCorp
9/23/2020
LabCorp, a leading global life sciences company that is focused on advancing health and guiding patient care decisions, has launched a new, non-invasive test for patients with non-small cell lung cancer.
-
Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation
9/16/2020
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with LabCorp’s drug development business, Covance. LabCorp will participate in Tempus's TIME Trial® Network and the companies will work together to accelerate patient enrollment
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 9, 2020.
-
LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season
9/8/2020
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
-
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
7/30/2020
More details of the three-month program will be provided in the near future.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 29, 2020.
-
LabCorp Announces 2020 Second Quarter Results
7/28/2020
LabCorp announced results for the second quarter ended June 30, 2020.
-
LabCorp Receives Authorization for COVID-19 Sample Pooling
7/25/2020
New Method Aims to Improve Efficiency of COVID-19 Testing, Optimize Testing Supplies and Increase Overall Capacity
-
LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience
7/7/2020
LabCorp (NYSE: LH) today launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital service aimed at helping doctors protect patients by testing them for COVID-19 before surgeries and other important treatments.
-
LabCorp to Announce Second Quarter Financial Results on July 28, 2020
7/6/2020
LabCorp (NYSE: LH) will release its second quarter of 2020 financial results before the market opens on Tuesday, July 28, 2020, and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results
-
LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution
6/29/2020
Advanced Analytics and Visualizations Empower Study Teams to Respond to Dynamic Environment, Manage Risk, Resume Studies and Safeguard Patients
-
The company announced its Covance drug development business was launching COVID-19 Clinical Trial Connect in the U.S. to help people find information on taking part in clinical trials related to COVID-19.